| abstract |
The present invention relates to the use of a therapeutically effective amount of compound A = 1 - [N2- [3,5-Dibromo-N- [[4- (3,4-dihydro-2 (1H) -oxoquinazolin-3- il) -1- piperidinill carbonill -D-tyrosyl] -L-lysyl] -4- (4-pyridinyl) -piperazine [BIBN4096BS] or one of its physiologically acceptable salts and a therapeutically effective amount of a second active anti-migraine drug , particularly sumatriptan, Zolmitriptan or dihydroergotamine or one of its physiologically acceptable salts, to prepare a medicament for treating or preventing headaches, migraines or cluster headaches, as well as the corresponding pharmaceutical compositions and application equipment. |